GLG Inc’s Mead Johnson Nutrition Company MJN Stock Holding History

GLG Inc’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-36,603	Closed	-$2.9M	–	782
2013 Q2	$2.9M	Buy	+36,603	New	+$2.93M	0.07%	249

Other funds holding MJN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GLG Inc's MJN Position: Q3 2013 in Review

GLG Inc sold out of Mead Johnson Nutrition Company (MJN) in Q3 2013, closing a stake of 36,603 shares — an estimated $2.9M sold.

GLG Inc first reported a position in MJN in Q2 2013 and held it in 1 quarter. The position peaked at $2.9M in Q2 2013. 450 funds tracked by Wall St. Rank hold MJN as of Q3 2013.

GLG Inc reported no remaining Mead Johnson Nutrition Company position as of Q3 2013 after selling out during the quarter.
GLG Inc sold 36,603 Mead Johnson Nutrition Company shares in Q3 2013, an estimated $2.9M.
GLG Inc first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 1 quarter.
GLG Inc's Mead Johnson Nutrition Company position peaked at $2.9M in Q2 2013.
450 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2013.

Based on GLG Inc's 13F filing for Q3 2013, filed 14 Nov 2013.